Compare ARTL & CETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARTL | CETX |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4M | 3.5M |
| IPO Year | N/A | 1998 |
| Metric | ARTL | CETX |
|---|---|---|
| Price | $1.84 | $2.60 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $30.00 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 140.1K |
| Earning Date | 11-12-2025 | 12-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $76,095,551.00 |
| Revenue This Year | N/A | $19.77 |
| Revenue Next Year | N/A | $15.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.50 |
| 52 Week Low | $1.52 | $2.50 |
| 52 Week High | $28.60 | $57.75 |
| Indicator | ARTL | CETX |
|---|---|---|
| Relative Strength Index (RSI) | 33.96 | 35.87 |
| Support Level | $1.62 | $2.86 |
| Resistance Level | $1.98 | $3.42 |
| Average True Range (ATR) | 0.19 | 0.42 |
| MACD | 0.11 | -0.08 |
| Stochastic Oscillator | 69.53 | 4.41 |
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.